In Memoriam Gérard Siest
Dear ESPT members and readers of DMPT,
We are deeply saddened to announce that our President and Honorary Editor of Drug Metabolism and Personalized Therapy, Professor Gérard Siest, passed away on Saturday, April 9th 2016.
Dr. Siest was Emeritus Professor of Molecular Biology and Biochemical Pharmacology at the Faculty of Pharmaceutical Sciences and former director of the postgraduate course in Biochemical Pharmacology at the University Henri Poincaré (currently ‘Université de Lorraine’) in Nancy, France. He was also the founder and head of the clinical laboratory and research group of the “Centre de Médecine Preventive” in Nancy for 37 years (1968–2005), and at the same time director of a research laboratory called “Centre du Médicament” at the Faculty of Pharmacy in Nancy (1987–2004).
As an extremely hardworking person Prof. Gérard Siest was well known to the scientific community as author of more than 800 publications in peer reviewed journals and his work was honoured by 27 awards from 16 different countries. He was strongly involved in activities of many international and European professional societies and editoral boards. He served as President of the IFCC from 1991 until 1996. Since 2011, he dedicated his life to the development of the European Society of Pharmacogenetics and Personalised Therapy (ESPT), which under his inspired leadership has gained worldwide visibility, and which is now an important scientific stakeholder in the field of pharmacogenomics and personalised medicine.
Gérard’s sudden death leaves a huge gap in the ESPT community. We will miss him sorely, for many reasons, including his tireless enthusiasm, and in particular for his visionary leadership in implementing pharmacogenomics into clinical practice.
The members of the ESPT Executive Board deeply mourn an outstanding person and send their sincerest condolences to his family.
Vangelis G. Manolopoulos
Ron H.N. van Schaik
Sophie Visvikis-Siest
Janja Marc
Maurizio Simmaco
Peter Jacobs
Ingolf Cascorbi
Marc Ansari
Adrian LLerena
©2016 by De Gruyter
Articles in the same Issue
- Frontmatter
- In Memoriam Gérard Siest
- Reviews
- Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)
- Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen
- Mini Reviews
- The integration and interpretation of pharmacogenomics – a comparative study between the United States of America and Europe: towards better health care
- Investigating the impact of missense mutations in hCES1 by in silico structure-based approaches
- Original Articles
- Lack of genomic diversity in the SLC47A1 gene within the indigenous Xhosa population
- Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes
- Altered pharmacokinetics and pharmacodynamics of repaglinide by ritonavir in rats with healthy, diabetic and impaired hepatic function
Articles in the same Issue
- Frontmatter
- In Memoriam Gérard Siest
- Reviews
- Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)
- Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen
- Mini Reviews
- The integration and interpretation of pharmacogenomics – a comparative study between the United States of America and Europe: towards better health care
- Investigating the impact of missense mutations in hCES1 by in silico structure-based approaches
- Original Articles
- Lack of genomic diversity in the SLC47A1 gene within the indigenous Xhosa population
- Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes
- Altered pharmacokinetics and pharmacodynamics of repaglinide by ritonavir in rats with healthy, diabetic and impaired hepatic function
